Pauline Coquart

Ms. Pauline Coquart

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
PCPauline Coquart
Pauline Coquart
AHAndrea El Haddad
Andrea El Haddad
Dimitrios KoutsourasDimitrios Koutsouras
Dimitrios Koutsouras
JBJohanna Bolander
Johanna Bolander
The growing burden of degenerative, cardiovascular, neurodegenerative, and cancerous diseases necessitates innovative approaches to improve our pathophysiological understanding and ability to modulate biological processes. Organic bioelectronics has emerged as a powerful tool in this pursuit, offering a unique ability to interact with biology due to the mixed ionic–electronic conduction and tissue-mimetic mechanical properties of conducting polymers (CPs). These materials enable seamless integration with biological systems across different levels of complexity, from monolayers to complex 3D models, microfluidic chips, and even clinical applications. CPs can be processed into diverse formats, including thin films, hydrogels, 3D scaffolds, and electrospun fibers, allowing the fabrication of advanced bioelectronic devices such as multi-electrode arrays, transistors (EGOFETs, OECTs), ion pumps, and photoactuators. This review examines the integration of CP-based bioelectronics in vivo and in in vitro microphysiological systems, focusing on their ability to monitor key biological events, including electrical activity, metabolic changes, and biomarker concentrations, as well as their potential for electrical, mechanical, and chemical stimulation. We highlight the versatility and biocompatibility of CPs and their role in advancing personalized medicine and regenerative therapies and discuss future directions for organic bioelectronics to bridge the gap between biological systems and electronic technologies.

14 October 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
NDNeha Deshpande
Neha Deshpande
PCPauline Coquart
Pauline Coquart
BTBram Theuns
Bram Theuns
SCSusanne Cremery
Susanne Cremery
JIJaime Rodolfo V. Garcia Iii
Jaime Rodolfo V. Garcia Iii
JBJohanna Bolander
Johanna Bolander
Fibrosis is a major cause of chronic tissue dysfunction and contributes substantially to morbidity and mortality worldwide. Osteoarthritis (OA), affecting over 590 million people, is a prevalent fibrotic joint disease for which disease‐modifying therapies remain lacking, partly because disease progression remains incompletely understood. As human‐relevant in vitro models, including organ‐on‐chip and microphysiological systems, become increasingly important, non‐invasive technologies capable of continuous cellular monitoring are urgently needed. Here, we implement high‐density complementary metal‐oxide‐semiconductor (CMOS) multielectrode array (MEA)‐based impedance profiling as a label‐free platform for longitudinal assessment of OA‐relevant chondrocyte remodeling. Human primary chondrocytes cultured on CMOS‐MEA chips exhibited impedance increases that correlated with electrode occupancy and extracellular matrix (ECM) deposition. Spatial impedance mapping enabled visualization of injury‐response dynamics, while oxidative stress induced progressive impedance decline accompanied by apoptosis, morphological remodeling, and chondrocyte dedifferentiation, evidenced by reduced collagen II and SOX9 expression and increased collagen I expression. In contrast, osteogenic de‐differentiation produced increased impedance associated with ECM remodeling and matrix mineralization. Together, these findings support high‐density CMOS‐MEA impedance profiling as a non‐invasive approach for monitoring cellular remodeling and provide a foundation for future integration of spatially resolved impedance sensing into advanced microphysiological systems for OA and other fibrotic diseases.